Pimobendan is used in the management of heart failure in dogs, most commonly caused by myxomatous mitral valve disease, or dilated cardiomyopathy. Pimobendan is a veterinary medication.Reference standards of Pimobendan API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Pimobendan
Catalogue No.:PA 69 13000
CAS :
Molecular Formula : C19H18N4O2
Molecular Weight : 334.37
(3RS)-4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic Acid
Catalogue No.:PA 69 13010
Molecular Formula : C19H18N2O4
Molecular Weight : 338.36
N-[2-Amino-4-[(4RS)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl]-4-methoxybenzamide
Catalogue No.:PA 69 13020
Molecular Formula : C19H20N4O3
Molecular Weight : 352.39
Pimobendan for system suitability (Y0000401)
Catalogue No.:PA EPY0000401
Molecular Formula : NA
Molecular Weight : NA
Pimobendan (Y0000525)
Catalogue No.:PA EPY0000525
Pimobendan (1569315)
Catalogue No.:PA USP1569315
Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl (1569337)
Catalogue No.:PA USP1569337
d-Pimobendan
Catalogue No.:PA 69 13510
Molecular Weight : 334.38
i-Pimobendan
Catalogue No.:PA 69 13520
O-Desmethylpimobendan
Catalogue No.:PA 69 0131000
Molecular Formula : C18H16N4O2
Molecular Weight : 320.35
Pimobendan-d3
Catalogue No.:PA STI 089293
Molecular Formula : C19H15D3N4O2
Molecular Weight : 337.4
6-(3,4-Diaminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one
Catalogue No.:PA 69 0131001
Molecular Formula : C11H14N4O
Molecular Weight : 218.26
6-(2-(4-Methoxyphenyl)-1-nitroso-1H-benzo[d]imidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one
Catalogue No.:PA 69 0131002
Molecular Formula : C19H17N5O3
Molecular Weight : 363.38
N-(2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-N-benzylnitrous amide
Catalogue No.:PA 69 0131003
Molecular Formula : C18H19N5O2
Molecular Weight : 337.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
